"INTEGRATIVE AYURVEDIC MANAGEMENT OF ISCHEMIC HEART DISEASE WITH REGIONAL WALL MOTION ABNORMALITY: A CASE REPORT"
Main Article Content
Keywords
Ischemic heart disease, Regional wall motion abnormality, Traditional medicine, Integrative approach, Heart function
Abstract
This case report showcases the effective management of ischemic heart disease (IHD) with regional wall motion abnormality (RWMA) through an integrated Ayurvedic treatment approach. A 60-year-old male with a history of IHD, dyslipidaemia, and hypertension experienced significant improvements in both subjective and objective parameters following two admissions and a treatment regimen consisting of oral medications and Panchakarma therapies. Subjective improvements included the alleviation of exertional breathlessness and notable enhancements in physical endurance as measured by the 6-Minute Walk Distance (6MWD) and cardiovascular efficiency (VO2MAX). Objective assessments revealed the resolution of RWMA, improvements in left ventricular function, and an increase in left ventricular ejection fraction (LVEF). The treatment approach involved preparatory detoxification, targeted Panchakarma therapies, and specific oral medications addressing dyslipidaemia and cardiovascular function, such as Kostashodana, Basti therapies, and herbal formulations like Arogyavardini Vati and Prabhakar Vati. This case underscores the potential of Ayurveda as a complementary approach in the comprehensive management of cardiovascular conditions, offering holistic benefits that extend beyond mere symptomatic relief.
Downloads
References
1. Collins M, Hsieh A, Ohazama CJ, et al. Assessment of regional wall motion abnormalities with real-time 3-dimensional echocardiography. J Am Soc Echocardiogr. 1999;12(1):7-14. doi:10.1016/s0894-7317(99)70167-7 2. Opthof T, Sutton P, Coronel R, Wright S, Kallis P, Taggart P. The Association of Abnormal Ventricular Wall Motion and Increased Dispersion of Repolarization in Humans is Independent of the Presence of Myocardial Infarction. Front Physiol. 2012;3:235. Published 2012 Jul 3. doi:10.3389/fphys.2012.00235 3. Medina R, Panidis IP, Morganroth J, Kotler MN, Mintz GS. The value of echocardiographic regional wall motion abnormalities in detecting coronary artery disease in patients with or without a dilated left ventricle. Am Heart J. 1985;109(4):799-803. doi:10.1016/0002-8703(85)90641-6 4. Playford D, Stewart S, Harris SA, Chan YK, Strange G. Pattern and Prognostic Impact of Regional Wall Motion Abnormalities in 255 697 Men and 236 641 Women Investigated with Echocardiography. J Am Heart Assoc. Published online November 10, 2023. doi:10.1161/JAHA.123.031243 5. Severino P, D'Amato A, Pucci M, et al. Ischemic Heart Disease Pathophysiology Paradigms Overview: From Plaque Activation to Microvascular Dysfunction. Int J Mol Sci. 2020;21(21):8118. Published 2020 Oct 30. doi:10.3390/ijms21218118 6. Jeroudi MO, Cheirif J, Habib G, Bolli R. Prolonged wall motion abnormalities after chest pain at rest in patients with unstable angina: a possible manifestation of myocardial stunning. Am Heart J. 1994;127(5):1241-1250. doi:10.1016/0002-8703(94)90042-6 7. Pratibha Lokhande, Babita Sharma, & Nitin Ujjaliya. (2024). An integrated approach in the management of cardiovascular diseases. Journal of Ayurveda and Integrated Medical Sciences, 9(1), 95 - 99. https://doi.org/10.21760/jaims.9.1.12 8. Wallace RK. The Microbiome in Health and Disease from the Perspective of Modern Medicine and Ayurveda. Medicina (Kaunas). 2020;56(9):462. Published 2020 Sep 11. doi:10.3390/medicina56090462 9. Ramraj Singh, Rupali Kakade, Jayant Gulhane, Therapeutic aspects of Eranda Tail (Oil of Ricinus Communis). J Ayu Int MedSci. 2023;8(4):158-165. https://jaims.in/jaims/article/view/2413 10. Kumar G, Srivastava A, Sharma SK, Gupta YK. The hypolipidemic activity of Ayurvedic medicine, Arogyavardhini vati in Triton WR-1339-induced hyperlipidemic rats: A comparison with fenofibrate. J Ayurveda Integr Med. 2013;4(3):165-170. doi:10.4103/0975-9476.118707 11. Thanki K, Bhatt N, Shukla VD. Effect of kshara basti and nirgundi ghana vati on amavata (rheumatoid arthritis). Ayu. 2012;33(1):50-53. doi:10.4103/0974-8520.100310 12. Kadus PA, Vedpathak SM. Anuvasan Basti in escalating dose is an alternative for Snehapana before Vamana and Virechana: Trends from a pilot study. J Ayurveda Integr Med. 2014;5(4):246-250. doi:10.4103/0975-9476.147445 13. Parekar RR, Bolegave SS, Marathe PA, Rege NN. Experimental evaluation of analgesic, anti-inflammatory and anti-platelet potential of Dashamoola. J Ayurveda Integr Med. 2015;6(1):11-18. doi:10.4103/0975-9476.146565 14. Ramesh P, Palaniappan A. Terminalia arjuna, a Cardioprotective Herbal Medicine-Relevancy in the Modern Era of Pharmaceuticals and Green Nanomedicine-A Review. Pharmaceuticals (Basel). 2023;16(1):126. Published 2023 Jan 13. doi:10.3390/ph16010126 15. Judy M. Muller-Delp, "The Coronary Microcirculation in Health and Disease", International Scholarly Research Notices, vol. 2013, Article ID 238979, 24 pages, 2013. https://doi.org/10.1155/2013/238979 16. Szapary PO, Wolfe ML, Bloedon LT, et al. Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial. JAMA. 2003;290(6):765-772. doi:10.1001/jama.290.6.765 17. Kumar G, Srivastava A, Sharma SK, Gupta YK. The hypolipidemic activity of Ayurvedic medicine, Arogyavardhini vati in Triton WR-1339-induced hyperlipidemic rats: A comparison with fenofibrate. J Ayurveda Integr Med. 2013;4(3):165-170. doi:10.4103/0975-9476.118707 18. Wen M, Chen Q, Chen W, et al. A comprehensive review of Rubia cordifolia L.: Traditional uses, phytochemistry, pharmacological activities, and clinical applications. Front Pharmacol. 2022;13:965390. Published 2022 Sep 9. doi:10.3389/fphar.2022.965390 19. Prasad S, Srivastava SK. Oxidative Stress and Cancer: Chemopreventive and Therapeutic Role of Triphala. Antioxidants (Basel). 2020;9(1):72. Published 2020 Jan 13. doi:10.3390/antiox9010072 20. Adegbola P, Aderibigbe I, Hammed W, Omotayo T. Antioxidant and anti-inflammatory medicinal plants have potential role in the treatment of cardiovascular disease: a review. Am J Cardiovasc Dis. 2017;7(2):19-32. Published 2017 Apr 15. 21. Sharma R, Goyal A, Singh R, et al. Effect of Ayurveda intervention in the integrated management of essential hypertension- a retrospective observational study. J Ayurveda Integr Med. 2021;12(3):521-528. doi:10.1016/j.jaim.2021.04.012 22. Bhat MDA, Malik SA. Efficacy of Nardostachys jatamansi (D.Don) DC in essential hypertension: A randomized controlled study. Complement Ther Med. 2020;53:102532. doi:10.1016/j.ctim.2020.102532 23. Nagarajan M, Kuruvilla GR, Kumar KS, Venkatasubramanian P. Pharmacology of Ativisha, Musta and their substitutes. J Ayurveda Integr Med. 2015;6(2):121-133. doi:10.4103/0975-9476.146551
Article Sidebar
Article Details
Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.